GenoLogics Releases BioVault Biospecimen Management Software in Partnership with GenVault
News May 28, 2008
GenoLogics has announced its partnership with GenVault Corporation for its biospecimen data management system, BioVault.
“We recognize the significance of biospecimen repositories with well annotated clinical information to biomedical research and have embarked on a strategic endeavor to provide a full product line of integrated software systems”, says GenoLogics’ VP of Market Strategy, James DeGreef.
“We are excited about releasing our first biomedical product, BioVault, which is part of our total solution to help clients better manage their biosamples and related data”.
GenoLogics launched its Biomedical Informatics software solution to track observational studies, collect patient data at remote sites, provide biospecimen and clinical annotations management and facilitate researchers querying on clinical information and requesting samples. The suite is comprised of five integrated products, including BioVault for biospecimen management, which GenoLogics is partnering with GenVault, a vendor of biosample management solutions.
“Our experience with helping clients to stabilize their biosamples at room temperature and seamlessly manage their transport, storage and retrieval complements GenoLogics’ experience in providing lab and data management software solutions to research organizations”, says Dr. David Wellis, CEO of GenVault.
“Our biospecimen consumable, hardware and software technologies were built to allow for full integration with software applications such as the Biomedical Informatics products GenoLogics is building."
GenoLogics is developing their Biomedical Informatics product line as a complement to their existing Research Informatics product line. The biomedical and research product lines, combined with the ability to provide data warehouse services, enables GenoLogics to deploy an effective solution for clients to manage their translational research initiatives.
Hay Fever Risk Genes Overlap with Autoimmune DiseaseNews
In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.READ MORE
Hidden Signals in RNAs Regulate Protein SynthesisNews
Scientists have long known that RNA encodes instructions to make proteins. In a new study published in Nature, scientists describe how the protein-making machinery identifies alternative initiation sites from which to start protein synthesis.READ MORE
ExPecto Patronum! Magical Machine Learning Tool Summons DNA Dark Matter DataNews
A new machine learning framework, dubbed ExPecto, can predict the effects of mutations in the so-called “dark matter” regions of the human genome. ExPecto pinpoints how mutations can disrupt the way genes turn on and off throughout your body.